• Clinigen Healthcare, of Burton-on-Trent, UK, the pharmaceutical products division of Clinigen Group, said its supplemental new drug application for Foscavir (foscarnet sodium) in HIV/AIDS-related cytomegalovirus infections and herpes was approved by the FDA.